Malaria: all 1,315 studies
Page 5 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel SitesCompletedNCT05070520Phase 4
- Therapeutic Efficacy Study of AL and DP in Western KenyaCompletedNCT05060198Not applicable
- Plasmodium Vivax Among Duffy Negative Population in Cameroon.Status unknownNCT05058885
- Validation of a CDSA Strategy to Reduce Antibiotic Prescription in SenegalCompletedNCT05050825Not applicable
- Village Malaria Worker ExpansionCompletedNCT05045547
- Study to Evaluate Primaquine for Radical Cure of Uncomplicated Plasmodium Vivax Malaria in ChildrenCompletedNCT05044637Phase 2
- Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in MyanmarStatus unknownNCT05025761Not applicable
- Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)Active, not recruitingNCT04978272Phase 3
- Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, GuineaCompletedNCT04969913
- Association Between Drug Levels, Malaria, and Antimalarial Resistance in the Setting of Seasonal Malaria ChemopreventionCompletedNCT04969185
- Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve AdultsCompletedNCT04966871Phase 1
- Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)CompletedNCT04966702Phase 3
- Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated MalariaCompletedNCT04944966Phase 2
- Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating MalariaCompletedNCT04897919Phase 4
- Assessment of the Therapeutic Efficacy and Tolerability of the Artesunate/Amodiaquina Combination and Artemether/Lumefantrine Combination, Treatment of Uncomplicated P. Falciparum Malaria in the Department of Chocó (Colombia)CompletedNCT04877626Phase 4
- Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination ActivitiesCompletedNCT04864444Not applicable
- Malawi International Center of Excellence in Malaria Research School-based CohortCompletedNCT04858087
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 3
- Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell AnaemiaCompletedNCT04844099Phase 3
- Proactive Community Case Management for Malaria in ZambiaCompletedNCT04839900Not applicable
- Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in CameroonStatus unknownNCT04829695Phase 4
- MiMBa Pregnancy RegistryCompletedNCT04825782
- Boosting the Impact of SMC Through Simultaneous Screening and Treatment of RoommatesCompletedNCT04816461Phase 4
- Attractive Targeted Sugar Bait Phase III Trial in ZambiaActive, not recruitingNCT04800055Not applicable
- Spatial Repellents for Vector ControlCompletedNCT04795648Not applicable
- Clinical Evaluation of the STANDARD™ Q Malaria/CRP Duo TestCompletedNCT04791800
- A Study of Blood-stage Controlled Human Plasmodium Falciparum Malaria Infection in TanzaniaCompletedNCT04788862Not applicable
- Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)CompletedNCT04783051Phase 3
- Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)Status unknownNCT04778813Phase 4
- Malaria Therapeutic Efficacy Study, RwandaCompletedNCT04767217Phase 4
- Malaria Therapeutic Efficacy Study (TES) KenyaCompletedNCT04767191Phase 4
- Spatial Repellents for the Prevention of Malaria in KenyaCompletedNCT04766879Not applicable
- Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune VolunteersStatus unknownNCT04739917Phase 2
- Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in MozambiqueCompletedNCT04724161
- Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in MozambiqueCompletedNCT04716387
- Optimizing Malaria Treatment for HIV-Malaria Co-infected IndividualsStatus unknownNCT04708496Phase 4
- R21/Matrix-M in African Children Against Clinical MalariaActive, not recruitingNCT04704830Phase 3
- Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, LiberiaActive, not recruitingNCT04704674
- Evaluation of the STANDARD G6PD Rapid Test for Assaying the Enzymatic Activity of G6PD in French GuianaStatus unknownNCT04698980Not applicable
- Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in MyanmarStatus unknownNCT04695886Not applicable
- Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina FasoCompletedNCT04695197Phase 3
- Household-level Impact of IPT of Malaria in SchoolchildrenStatus unknownNCT04660110Phase 3
- Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina FasoCompletedNCT04650815
- Assessing to What Extent Dhps-431V Mutation May Influence the Protective Efficacy of IPTp-SPStatus unknownNCT04634695
- Uganda Housing Modification StudyStatus unknownNCT04622241Not applicable
- Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the CongoCompletedNCT04618523Phase 4
- Baseline Cohort Malaria Morbidity StudyCompletedNCT04601714
- Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.CompletedNCT04577066Phase 1/2
- Mobilization at the Level of Schools on the Behavioral Change in Favor of the Fight Against Malaria in MbandjockStatus unknownNCT04570241Not applicable
- Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in YaoundeCompletedNCT04565184Phase 4
- Innovation PlatformCompletedNCT04558528
- Automated Microscopy Evaluation StudyCompletedNCT04558515
- Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina FasoCompletedNCT04545905
- Star Homes Project 2CompletedNCT04529434Not applicable
- Very Severe Malaria Treated by Intravenous ArtesunateCompletedNCT04516317
- Perceptions, Representations and Experiences of Malaria Prophylaxis in Patients Born in Endemic Areas and Living in France.CompletedNCT04494854
- Characterizing Humoral Immune Response to Mosquito BitesCompletedNCT04478370Not applicable
- Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in ChildrenCompletedNCT04473768
- The Malaria Heart Disease StudyTerminatedNCT04445103
- Biological Mechanisms in Afebrile P. Falciparum MalariaCompletedNCT04422015
- Evaluation of IR3535 as a Spatial Repellent for Malaria Control.Active, not recruitingNCT04419766Not applicable
- Pregnant Women for Malaria SurveillanceCompletedNCT04412005
- Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and PrimaquineCompletedNCT04411836Phase 3
- In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)CompletedNCT04370977Phase 4
- RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in MalawiCompletedNCT04327440
- Clinical Study of Meplazumab to Treat With MalariaWithdrawnNCT04327310Phase 1
- Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in TanzaniaCompletedNCT04318002Phase 1
- Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in GhanaCompletedNCT04301531Not applicable
- A Trial For The Study of Falciparum Malaria Protein 014 Administered Via Intramuscular Injection in Healthy AdultsStatus unknownNCT04296279Phase 1
- Health Itinerary of Young Children With Suspected Bloodstream Infection in Kisantu General Referral Hospital, DR CongoCompletedNCT04289688
- Nitrite Infusion in Children With MalariaWithdrawnNCT04289558Phase 1
- Controlled Human Malaria Infection Transmission Model - Phase ASuspendedNCT04280692Phase 1/2
- Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.TerminatedNCT04271306Phase 1
- A Trial For The Study of Falciparum Malaria Protein 013 Administered Via Intramuscular Injection in Healthy AdultsStatus unknownNCT04268420Phase 1
- Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination TherapiesCompletedNCT04265573
- Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infectionCompletedNCT04264130Phase 2
- Strategies to Increase Antenatal Iron and Folic Acid Supplementation and Malaria ProphylaxisStatus unknownNCT04250428Not applicable
- Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaCompletedNCT04245033Phase 4
- Evaluation of Targeted Mass Drug Administration for Malaria in EthiopiaStatus unknownNCT04241705Not applicable
- Assessment of a Combined Strategy of SMC + Nutrients Supplementation to Tackle Malaria and MalnutritionStatus unknownNCT04238845Not applicable
- Improving Care Through Azithromycin Research for Infants in AfricaActive, not recruitingNCT04235816Phase 3
- Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in RwandaCompletedNCT04230161
- Biomarkers of P. Vivax RelapseStatus unknownNCT04228315Not applicable
- A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)WithdrawnNCT04203186Not applicable
- The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive TractCompletedNCT04189744Phase 3
- Adaptive Interventions for Optimizing Malaria Control: a Cluster-Randomized SMART TrialCompletedNCT04182126Not applicable
- Lung Ultrasound in Children With Severe MalariaCompletedNCT04176029
- Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among ChildrenCompletedNCT04167566Not applicable
- Acceptability and Feasibility in the Context of the IMPROVE Trial in KenyaCompletedNCT04160026Phase 4
- Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)CompletedNCT04158713Phase 3
- Estimating the Malaria Prevention Impact of New Nets: Observational Analyses to Evaluate the Evidence Generated During Piloted New Net Distributions in Burkina FasoCompletedNCT04157894
- Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+AmodiaquinStatus unknownNCT04149106Phase 3
- Assessing the Impact of Group Antenatal Care on IPTp Uptake in TanzaniaTerminatedNCT04148690Not applicable
- Additional Screening With Sensitives RDTs and MalariaCompletedNCT04147546Phase 3
- VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M VaccineTerminatedNCT04130282Phase 1
- Malaria Prevalence Around Maferinyah, GuineaCompletedNCT04105855
- Getting Malaria "Off the Back" of Women and Children in Western UgandaCompletedNCT04102592Not applicable
- Malaria High-Risk Populations in NamibiaCompletedNCT04094727Phase 4
- Mass Screening and Treatment for Reduction of Falciparum MalariaCompletedNCT04093765Not applicable
- Short Course Radical Cure of P. Vivax Malaria in NepalCompletedNCT04079621Phase 4